Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer

被引：0
|
作者：
Takahiro Tsushima
Shuichi Hironaka
Narikazu Boku
Nozomu Machida
Kentaro Yamazaki
Hirofumi Yasui
Keisei Taku
Akira Fukutomi
Yusuke Onozawa
机构：
[1] Shizuoka Cancer Center,Division of Gastrointestinal Oncology
[2] Chiba Cancer Center,Clinical Research Promotion Department
来源：
Gastric Cancer | 2010年 / 13卷
关键词：
S-1; Elderly; Gastric Cancer; Safety; Efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：245 / 250
页数：5
相关论文
共 50 条
  • [41] SAFETY AND EFFICACY OF ALBUMIN-BOUND PACLITAXEL AND OXALIPLATIN AND S-1 AS FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED GASTRIC CANCER
    Lou, H.
    Pan, H.
    Pan, Q.
    Li, D.
    Jin, W.
    ANNALS OF ONCOLOGY, 2012, 23 : 256 - 256
  • [42] Clinical impact of renal impairment on the safety and efficacy of S-1 plus oxaliplatin in patients with advanced gastric cancer: a single institutional study
    Demachi, Ken
    Bando, Hideaki
    Nomura, Hisanaga
    Shitara, Kohei
    Yoshino, Takayuki
    Yamaguchi, Masakazu
    Kawasaki, Toshikatsu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (02) : 129 - 137
  • [43] Pharmacokinetics (PK) of S-1 monotherapy in plasma and in tears for gastric cancer patients (pts).
    Kawakami, Takeshi
    Kashiwagi, Hiroya
    Mori, Keita
    Omae, Katsuhiro
    Kasai, Jun
    Yoshisue, Kunihiro
    Kawahira, Masahiro
    Tsushima, Takahiro
    Machida, Nozomu
    Fukutomi, Akira
    Yamaguchi, Ken
    Yasui, Hirofumi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [44] Reduction in Gastrointestinal Toxicity by Gastric Secretion Inhibitors during S-1 Monotherapy for Patients with Gastric Cancer
    Chisaki, Yugo
    Noda, Satoshi
    Hira, Daiki
    Morita, Shin-ya
    Yano, Yoshitaka
    Terada, Tomohiro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2014, 37 (07) : 1158 - 1161
  • [45] S-1-based therapy versus S-1 monotherapy in advanced gastric cancer: a meta-analysis
    Wu, Jun-Rong
    Tang, Wei-Zhong
    Chen, Xi
    Xie, Yan-Tong
    Chen, Si-Yuan
    Peng, Qi-Liu
    Xie, Li
    Deng, Yan
    Li, Tai-Jie
    He, Yu
    Wang, Jian
    Li, Shan
    Qin, Xue
    TUMOR BIOLOGY, 2014, 35 (04) : 3283 - 3293
  • [46] EFFICACY AND SAFETY OF S-1 AS SECOND-LINE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED BILIARY TRACT CANCER
    Kobayashi, S.
    Ueno, M.
    Ohkawa, S.
    Andou, T.
    Kameda, R.
    ANNALS OF ONCOLOGY, 2012, 23 : 121 - 121
  • [47] Efficacy and safety of S-1 maintenance therapy in advanced nonsmall-cell lung cancer patients
    Xiao-Wei Cheng
    Wen-Hua Leng
    Chun-Ling Mu
    World Journal of Clinical Cases, 2020, (21) : 5172 - 5179
  • [48] Weekly docetaxel as monotherapy in advanced gastric cancer. Efficacy and safety in pre-treated patients, elderly patients or patients with an impaired performance status
    Abbrederis, K.
    Lorenzen, S.
    Duyster, J.
    von Weikersthal, Fischer L.
    Seroneit, T.
    Rothling, N.
    Peschel, C.
    Lordick, F.
    ANNALS OF ONCOLOGY, 2006, 17 : 49 - 49
  • [49] A phase II study of combination therapy with oral S-1 and cisplatin in elderly patients with advanced gastric cancer
    Yusuke Sasaki
    Satoru Iwasa
    Shunsuke Okazaki
    Masahiro Goto
    Yasushi Kojima
    Atsushi Naganuma
    Kengo Nagashima
    Yushi Nagai
    Hidekazu Hirano
    Yoshitaka Honma
    Atsuo Takashima
    Ken Kato
    Tetsuya Hamaguchi
    Gastric Cancer, 2018, 21 : 439 - 445
  • [50] A phase II study of combination therapy with oral S-1 and cisplatin in elderly patients with advanced gastric cancer
    Sasaki, Yusuke
    Iwasa, Satoru
    Okazaki, Shunsuke
    Goto, Masahiro
    Kojima, Yasushi
    Naganuma, Atsushi
    Nagashima, Kengo
    Nagai, Yushi
    Hirano, Hidekazu
    Honma, Yoshitaka
    Takashima, Atsuo
    Kato, Ken
    Hamaguchi, Tetsuya
    GASTRIC CANCER, 2018, 21 (03) : 439 - 445
12345